Sort by
Refine Your Search
-
Employer
-
Field
-
performance-based salary component is paid according to the appointee’s qualifications and experience. The appointee will be paid a salary component based on personal performance. The annual gross salary is
-
addition, the appointee will be paid a salary component based on personal performance. The starting salary is typically around 3700–4000 euros per month depending on the appointee’s qualifications and
-
-integral and nonequilibrium Green-function methods, complemented by numerical approaches based on tensor networks. The Condensed Matter Theory group of Tero Heikkilä has strong expertise in non-equilibrium
-
for the position will be based on level 5 of the job requirement scheme for teaching and research personnel in the salary system of Finnish universities. In addition, the appointee will be paid a salary component
-
based on level 5 of the job requirement scheme for teaching and research personnel in the salary system of Finnish universities. In addition, the appointee will be paid a salary component based on
-
requirement chart for teaching and research staff in the salary system of Finnish universities. In addition, the appointee will be paid a salary component based on personal work performance. The University
-
for our research, with a strong focus on digital data and methods. The successful candidate is expected to benefit from and collaborate with other team members, including the PI and approximately ten
-
strong focus on digital data and methods. The successful candidate is expected to benefit from and collaborate with other team members, including the PI and approximately ten other researchers (MSc and PhD
-
for teaching and research staff at Finnish universities. In addition, a salary component based on personal work performance will be paid (a maximum of 50 % of the job-specific component). The starting
-
the dynamics of therapy-resistance by combining advanced molecular biology method development to multi-omic single-cell analyses of both ex vivo models and clinical tumor specimens. Our novel, in-house